Effectiveness, safety and feasibility of recombinant hepatitis E vaccine HEV 239 (Hecolin) during an outbreak of hepatitis E in Bentiu, South Sudan

To estimate the protection conferred by 1 and 2 doses of HEV 239 vaccine against symptomatic hepatitis E. Despite numerous interventions since 2014, hepatitis E cases and deaths continue to be reported in Bentiu, including periods of increased tra...